Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Drucker

Showing results (81-90 of 313) with videos related to

Pageof 32
Sort By:
Gastroenterology|March 16, 2010
ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowelJasmine Bahrami, Bernardo Yusta, Daniel J Drucker
The Journal of Biological Chemistry|April 30, 2002
Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinaseBernardo Yusta, Jennifer Estall, Daniel J Drucker
Nature Reviews. Drug Discovery|April 2, 2010
LiraglutideDaniel J Drucker, Argyris Dritselis, Peter Kirkpatrick
JAMA|September 15, 2025
New Molecules and Indications for GLP-1 MedicinesMaria J Gonzalez-Rellan, Daniel J Drucker
Endocrinology|October 9, 2004
Pdx-1 is not sufficient for repression of proglucagon gene transcription in islet or enteroendocrine cellsGrace Flock, Xiemin Cao, Daniel J Drucker
Cell Reports. Medicine|July 16, 2025
The expanding benefits of GLP-1 medicinesMaria J Gonzalez-Rellan, Daniel J Drucker
Cell Reports. Medicine|December 17, 2025
Glucagon-like peptide-1 medicines in neurological and psychiatric disordersSusanna Fang, Fiona Cui, Daniel J Drucker
Endocrinology|October 11, 2008
Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouseIrene Hadjiyanni, Kunmin Karen Li, Daniel J Drucker
The New England Journal of Medicine|January 18, 2008
Clinical decisions. Management of type 2 diabetesRonald B Goldberg, Rury Holman, Daniel J Drucker
Endocrinology|July 21, 2011
Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cellsJacqueline A Koehler, Taylor Kain, Daniel J Drucker
Pageof 32

Showing results (81-90 of 313) with videos related to

Sort By:
Pageof 32
Gastroenterology|March 16, 2010
ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowelJasmine Bahrami, Bernardo Yusta, Daniel J Drucker
The Journal of Biological Chemistry|April 30, 2002
Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinaseBernardo Yusta, Jennifer Estall, Daniel J Drucker
Nature Reviews. Drug Discovery|April 2, 2010
LiraglutideDaniel J Drucker, Argyris Dritselis, Peter Kirkpatrick
JAMA|September 15, 2025
New Molecules and Indications for GLP-1 MedicinesMaria J Gonzalez-Rellan, Daniel J Drucker
Endocrinology|October 9, 2004
Pdx-1 is not sufficient for repression of proglucagon gene transcription in islet or enteroendocrine cellsGrace Flock, Xiemin Cao, Daniel J Drucker
Cell Reports. Medicine|July 16, 2025
The expanding benefits of GLP-1 medicinesMaria J Gonzalez-Rellan, Daniel J Drucker
Cell Reports. Medicine|December 17, 2025
Glucagon-like peptide-1 medicines in neurological and psychiatric disordersSusanna Fang, Fiona Cui, Daniel J Drucker
Endocrinology|October 11, 2008
Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouseIrene Hadjiyanni, Kunmin Karen Li, Daniel J Drucker
The New England Journal of Medicine|January 18, 2008
Clinical decisions. Management of type 2 diabetesRonald B Goldberg, Rury Holman, Daniel J Drucker
Endocrinology|July 21, 2011
Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cellsJacqueline A Koehler, Taylor Kain, Daniel J Drucker
Pageof 32